A purple and pink letter v on a white background.
November 19, 2018

NeoGraft® Launches New On-Demand Hair Transplant Technician Scheduling App For Physician Partners

Charlotte, NC (November 29, 2018)— NeoGraft®, an innovative global leader in precision FUE hair restoration technology, announces the launch of a new on-demand hair transplant technician scheduling app for their physician partners.

The NeoGrafters™ app for physicians is now available on Google Play and the App Store and was designed to help simplify and streamline the technician scheduling process for partners offering NeoGraft® follicular unit extraction (FUE) hair transplant services.

“On-demand services are becoming increasingly popular, so we looked for ways to improve our technician scheduling process for our physician partners,” said David Bays, Vice President of Business Development for Venus Concept, Ltd., the parent company for NeoGraft®. “Our new app will allow our NeoGraft® physicians to create a booking request, choose their preferred technicians based on availability, review all estimated charges, and submit right from their phones.  Once the procedures are completed, the physician can then review the final details, including graft counts, provide an in-app signature, and pay their balance via credit card,” Bays continued.

In addition to streamlining scheduling processes, NeoGraft® has enhanced their technician and nurse recruitment and training programs. “Our recruiting process is very selective and on average, our hair transplant professionals have a minimum of 10 years of experience,” said Stephani Boyd, Director of the NeoGrafters™ program. “We closely monitor each member of our team to ensure high standards are being maintained and require all to successfully complete a yearly recertification review. Working under the direct supervision of the practice physician, our experienced NeoGrafters™ professionals are there to ensure patient safety is maintained and best possible procedure outcomes are achieved,” Boyd continued.

For more information on NeoGrafters™ or to download the app, please visit www.neografters.com.

About NeoGraft®

Eight years ago, NeoGraft® launched its automated follicular unit extraction (FUE) system in North America. Today, NeoGraft® is considered one of the most trusted hair restoration brands in the world and collaborates with top aesthetic surgeons. By combining next-generation, minimally-invasive surgical techniques with decades of data, the company designed NeoGraft® 2.0 to be more than just a device—it is engineered to allow NeoGraft® to be true partners with physicians. The touchpad operates like your favorite tablet, and software communicates with the hand tools to provide real-time extract and implant graft counts. Today, NeoGraft® boasts over a 90% patient satisfaction rating on the world’s leading independent consumer website, RealSelf. For more information, please visit www.neograft.com.

About Venus Concept®

Venus Concept is a leading global medical technology company that develops, commercializes, and delivers safe, efficacious, and easy-to-use aesthetic technologies and related practice enhancement services in a unique, industry-disruptive subscription-based business model. Venus Concept's devices have been designed in cost-effective and proprietary ways that enable the company to expand beyond the aesthetic industry's traditional markets of dermatology and plastic surgery, and into non-traditional markets—such as family practice, general practice, internal medicine, obstetrics and gynecology, and medical spas. Approximately 70 percent of its devices are sold in non-traditional markets. The company has expanded its subscription platform and is now selling its devices in over 60 countries, including 27 with direct offices. Venus Concept now has over 400 global employees whose customer-centric approach has supported the company's rapid growth. For more information, please visit www.venusconcept.com.

By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.